Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
This study has found a novel epigenetic mechanism and a potential therapeutic strategy for AD and related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and inhibiting H3K4-specific methyltransferases, including MLL1-4 (also named as KMT2A-D) and SETD1a/b, leads to the substantial recovery of glutamatergic synaptic function in PFC pyramidal neurons, and the significant improvement of memory-related behaviors in mutant Tau transgenic mice 260.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [260]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the selective SGK1 inhibitor GSK650394 decreases Tau hyperphosphorylation, restores synaptic transmission, and ameliorate memory deficits in P301S mice [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“RNA sequencing (RNAseq) of the prefrontal cortex (PFC) of the P301S human Tau transgenic mouse model of dementia has identified Serum and Glucocorticoid-regulated Kinase-1 (Sgk1) as one of the top-ranking upregulated genes [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“SGK1 inhibition lowers pTau and rescues the deficits in synaptic transmission and memory tests in P301S mice [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the selective SGK1 inhibitor GSK650394 decreases Tau hyperphosphorylation, restores synaptic transmission, and ameliorate memory deficits in P301S mice [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 3×
“The transgenic mice carrying five familial AD mutations on human amyloid precursor protein (K670N/M671L + I716V + V717I) and human presenilin 1 (M146L + L286V), 5xFAD (27), were a gift from W. E. Van Nostrand (Stony Brook University).”
BackgroundInfluentialAdvancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
The contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585
Self-citationSingle-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Cited by
Items 101–110 of 110
Gojani, E. G., Farzin, H., Sutherland, R. J., & Mohajerani, M. H. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106619
SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients
Jiang, Z., Saleem, K., Fisher, E., Li, L., Yan, Z., & Feng, J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107345
“A variety of cellular stress, including oxidative stress, mitochondrial dysfunction, ER stress, misfolded protein stress, etc., are involved in the pathogenesis of AD (Butterfield and Halliwell, 2019; Salminen et al., 2009; Wang et al., 2020).”
InfluentialSelf-citationRen, Y., Saleem, K., Patel, P. J., Lee, Y.-H., Feng, J., & Yan, Z. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261427770
Self-citationKalra, P., Grewal, A. K., Khan, H., Chaturvedi, D., & Singh, T. G. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11892-x
“Furthermore, in P301S transgenic Tau mice (PS19), a comparable increase in H3K4me3 and KMT2A was also seen [35].”
Jaber, M., Mohamed, N., Inam, A., Suganth, S., & Dadhich, M. (2026) · JUNIOR RESEARCHERS · doi:10.52340/jr.2026.04.01.17
Zheng, X., Feng, H., Ren, L., & Zhang, Y. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04213-0
“Overall, our study presented an extensive cross-trait meta-analyses taking multiple ancestries into consideration, disentangling conditions with complex etiology while ensuring the discovery of shared genomic regions in the multi-trait scenario.”
ATF4–histone 2‐hydroxyisobutyrylation feedback loop drives sepsis‐induced inflammation
Zhang, L., Lu, Y., 裘红梅, 史新惠, Cao, F., Yang, T. T., Liu, S., Chen, Q., Jiang, Q., Xia, L., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70554
Carballo, L. G. H., Senek, R., Novototskaya-Vlasova, K., Li, P., Pletnikov, M., & Yan, Z. (2026) · Brain Communications · doi:10.1093/braincomms/fcag286
Self-citationEpigenetics in Alzheimer’s disease: from molecular mechanisms to emerging novel biomarkers
D’Aversa, E., Grisafi, M., Pernagallo, S., Salvatori, F., Singh, A. V., Nucciarone, A., Tisato, V., & Gemmati, D. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1959361
“Importantly, longitudinal evidence suggests that selected epigenetic changes may precede clinical conversion, highlighting their potential utility for identifying individuals at increased risk before overt cognitive impairment becomes apparent (Wang et al., 2020; Pérez et al., 2022).”
InfluentialLiang, J., Cao, H., 任秀敏, Sha, N., Han, X., Jiang, L., Liu, B., & Zhao, W. (2026) · Aging Cell · doi:10.1111/acel.70785
“…(G9a), and related agents have been reported to reduce H3K27me3/H3K18me/H3K9me2 and improve synaptic plasticity (Bellver-Sanchis et al. 2026; Cao et al. 2020; Griñán-Ferré et al. 2019; Li, Zhao, et al. 2022; Mu et al. 2020; Wang et al. 2023; Williams et al. 2023; Zhang, Wang, Zhou, et al.…”
Metadata
- Authors
- Cao, Q., Wang, W., Williams, J. B., Yang, F., Wang, Z.-J., & Yan, Z.
- Affiliations
- University at Buffalo, State University of New York (US)
- Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.
- Corresponding author
- Yan, Zhen
- Venue
- Science Advances
- Published
- 2020-12-11
- Volume
- 6
- Issue
- 50
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC7725456
- OpenAlex
- W3111509032
- Cited by
- 108
- References
- 73
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 23 · 2023: 21 · 2022: 17 · 2021: 8
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG064656, AG056060, AG067597)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- histone H3 lysine 4 trimethylation, Alzheimer's disease, SGK1, SGK1 inhibitor, tau hyperphosphorylation, prefrontal cortex, memory impairment, epigenetic therapy, cognitive impairment
- MeSH terms
- Alzheimer Disease, Animals, Cognition, Disease Models, Animal, Histones, Humans, tau Proteins, Epigenesis, Genetic, Intracellular Signaling Peptides and Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.